Literature DB >> 12648506

The final phase in acute myeloid leukaemia (AML). A study on bleeding, infection and pain.

Ann Marie Stalfelt1, Håkan Brodin, Solveig Pettersson, Anna Eklöf.   

Abstract

To increase the knowledge of the final phase of acute myeloid leukaemia (AML) a retrospective review of the medical and nursing records of 106 adult patients with AML who had died in 1995-1997 was made. A total of 27 patients were treated with curative intent at the time of death and 79 patients were prescribed palliative care. From the documentation, an evaluation of the frequency and severity of bleeding and pain episodes was made during their last week in life, and the occurrence of infection criteria was studied. Notations on bleeding were found in 44%, infection in 71% and pain in 76% of the patients. In 54% of the morphine administration days, no information on the effect of given morphine treatment was registered. To give AML patients in the final phase, the best possible treatment, skills in palliative medicine and palliative care are important.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12648506     DOI: 10.1016/s0145-2126(02)00262-x

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  6 in total

1.  Dying of hematologic patients--treatment characteristics in a German University Hospital.

Authors:  Patrick Brück; Malgorzata Pierzchlewska; Marta Kaluzna-Oleksy; Maria Elizabeth Ramos Lopez; Mathias Rummel; Dieter Hoelzer; Angelika Böhme
Journal:  Support Care Cancer       Date:  2012-03-13       Impact factor: 3.603

2.  Hospice admissions for cancer in the final days of life: independent predictors and implications for quality measures.

Authors:  Nina R O'Connor; Rong Hu; Pamela S Harris; Kevin Ache; David J Casarett
Journal:  J Clin Oncol       Date:  2014-08-25       Impact factor: 44.544

3.  Symptom burden and supportive care in patients with acute leukemia.

Authors:  Camilla Zimmermann; Dora Yuen; Ashley Mischitelle; Mark D Minden; Joseph M Brandwein; Aaron Schimmer; Lucia Gagliese; Christopher Lo; Anne Rydall; Gary Rodin
Journal:  Leuk Res       Date:  2013-03-11       Impact factor: 3.156

4.  Catastrophic bleeds during end-of-life care in haematology: controversies from Australian research.

Authors:  Pam McGrath; Michael Leahy
Journal:  Support Care Cancer       Date:  2008-09-23       Impact factor: 3.603

5.  Pain in blood cancers.

Authors:  Pasquale Niscola; Andrea Tendas; Laura Scaramucci; Marco Giovannini; Vitaliana De Sanctis
Journal:  Indian J Palliat Care       Date:  2011-09

Review 6.  A systematic review of prognostic factors at the end of life for people with a hematological malignancy.

Authors:  Elise Button; Raymond Javan Chan; Shirley Chambers; Jason Butler; Patsy Yates
Journal:  BMC Cancer       Date:  2017-03-23       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.